Larger studies of melatonin for depression/sleep needed

Autor: S Holt, MA Serfaty

Publikováno v: Focus on Alternative and Complementary Therapies. 15:317-318

Serfaty MA, Osborne D, Buszewicz MJ, Blizard R, Raven PW. A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood. Int Clin Psychopharma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9df9a63d8113c2a8bad257f0b1f77519
https://doi.org/10.1111/j.2042-7166.2010.01057_18.x

Cost-effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health-related quality of life.

Autor: Keetharuth AD; School of Medicine and Population Health, Sheffield Centre for Health and Related Research, University of Sheffield, Sheffield, UK., Gould RL; Division of Psychiatry, University College London, London, UK., McDermott CJ; Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK., Thompson BJ; Clinical Trials Research Unit, Sheffield Centre for Health and Related Research, University of Sheffield, Sheffield, UK., Rawlinson C; Division of Psychiatry, University College London, London, UK., Bradburn M; Clinical Trials Research Unit, Sheffield Centre for Health and Related Research, University of Sheffield, Sheffield, UK., Bursnall M; Clinical Trials Research Unit, Sheffield Centre for Health and Related Research, University of Sheffield, Sheffield, UK., Kumar P; Clinical Trials Research Unit, Sheffield Centre for Health and Related Research, University of Sheffield, Sheffield, UK., Turton EJ; Clinical Trials Research Unit, Sheffield Centre for Health and Related Research, University of Sheffield, Sheffield, UK., Tappenden P; School of Medicine and Population Health, Sheffield Centre for Health and Related Research, University of Sheffield, Sheffield, UK., White D; School of Medicine and Population Health, Sheffield Centre for Health and Related Research, University of Sheffield, Sheffield, UK., Howard RJ; Division of Psychiatry, University College London, London, UK., Serfaty MA; Division of Psychiatry, University College London, London, UK.; Priory Hospital North London, London, UK., McCracken LM; Department of Psychology, Uppsala University, Uppsala, Sweden., Graham CD; Department of Psychological Sciences & Health, University of Strathclyde, Glasgow, UK., Al-Chalabi A; Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK., Goldstein LH; Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK., Lawrence V; Health Service & Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK., Cooper C; Clinical Trials Research Unit, Sheffield Centre for Health and Related Research, University of Sheffield, Sheffield, UK., Young T; School of Medicine and Population Health, Sheffield Centre for Health and Related Research, University of Sheffield, Sheffield, UK.

Publikováno v: European journal of neurology [Eur J Neurol] 2024 Aug; Vol. 31 (8), pp. e16317. Date of Electronic Publication: 2024 Apr 25.

Acceptance and Commitment Therapy for people living with motor neuron disease: an uncontrolled feasibility study.

Autor: Gould RL; Division of Psychiatry, University College London, Wing B, 6th Floor Maple House, 149 Tottenham Court Rd, London, W1T 7NF, UK. r.gould@ucl.ac.uk., Rawlinson C; Division of Psychiatry, University College London, Wing B, 6th Floor Maple House, 149 Tottenham Court Rd, London, W1T 7NF, UK., Thompson B; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK., Weeks K; Division of Psychiatry, University College London, Wing B, 6th Floor Maple House, 149 Tottenham Court Rd, London, W1T 7NF, UK., Gossage-Worrall R; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK., Cantrill H; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK., Serfaty MA; Division of Psychiatry, University College London, Wing B, 6th Floor Maple House, 149 Tottenham Court Rd, London, W1T 7NF, UK.; Priory Hospital North London, London, UK., Graham CD; Strathclyde Psychology, Department of Psychological Sciences & Health, University of Strathclyde, Glasgow, UK., McCracken LM; Department of Psychology, Uppsala University, Uppsala, Sweden., White D; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK., Howard RJ; Division of Psychiatry, University College London, Wing B, 6th Floor Maple House, 149 Tottenham Court Rd, London, W1T 7NF, UK., Bursnall M; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK., Bradburn M; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK., Al-Chalabi A; Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK., Orrell R; Department of Clinical and Movement Neurosciences, Institute of Neurology, University College London, London, UK., Chhetri SK; Lancashire Teaching Hospitals NHS Foundation Trust, Lancashire, UK., Noad R; Department of Neuropsychology, Derriford Hospital, Plymouth, UK., Radunovic A; Barts Health NHS Trust, London, UK., Williams T; The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK., Young CA; The Walton Centre NHS Foundation Trust, Liverpool, UK., Dick D; Norfolk and Norwich University Hospital, Norwich, UK., Lawrence V; Health Services & Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK., Goldstein LH; Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK., Young T; School of Health and Related Research, University of Sheffield, Sheffield, UK., Ealing J; Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK., McLeod H; Mental Health and Wellbeing, University of Glasgow, Glasgow, UK., Williams N; Primary Care Clinical Trials Unit, Oxford University, Oxford, UK., Weatherly H; Centre for Health Economics, University of York, York, UK., Cave R; Language and Cognition, University College London, London, UK., Chiwera T; Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK., Pagnini F; Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy., Cooper C; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK., Shaw PJ; Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK., McDermott CJ; Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.

Publikováno v: Pilot and feasibility studies [Pilot Feasibility Stud] 2023 Jul 07; Vol. 9 (1), pp. 116. Date of Electronic Publication: 2023 Jul 07.

A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol.

Autor: Gould RL; Division of Psychiatry, University College London, Wing B, 6th floor Maple House, 149 Tottenham Court Rd, W1T 7NF, London, UK. r.gould@ucl.ac.uk., Thompson BJ; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK., Rawlinson C; Division of Psychiatry, University College London, Wing B, 6th floor Maple House, 149 Tottenham Court Rd, W1T 7NF, London, UK., Kumar P; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK., White D; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK., Serfaty MA; Division of Psychiatry, University College London, Wing B, 6th floor Maple House, 149 Tottenham Court Rd, W1T 7NF, London, UK.; Priory Hospital North London, London, UK., Graham CD; School of Psychology, Queen's University Belfast, Belfast, Northern Ireland., McCracken LM; Department of Psychology, Uppsala University, Uppsala, Sweden., Bursnall M; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK., Bradburn M; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK., Young T; School of Health and Related Research, University of Sheffield, Sheffield, UK., Howard RJ; Division of Psychiatry, University College London, Wing B, 6th floor Maple House, 149 Tottenham Court Rd, W1T 7NF, London, UK., Al-Chalabi A; Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK., Goldstein LH; Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK., Lawrence V; Health Services & Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK., Cooper C; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK., Shaw PJ; Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK., McDermott CJ; Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.

Publikováno v: BMC neurology [BMC Neurol] 2022 Nov 15; Vol. 22 (1), pp. 431. Date of Electronic Publication: 2022 Nov 15.

Acceptance and commitment therapy for older people with treatment-resistant generalised anxiety disorder: the FACTOID feasibility study.

Autor: Gould RL; Division of Psychiatry, Faculty of Brain Sciences, University College London, London, UK., Wetherell JL; Department of Psychiatry, VA San Diego Healthcare System, University of California San Diego, La Jolla, CA, USA., Serfaty MA; Division of Psychiatry, Faculty of Brain Sciences, University College London, London, UK., Kimona K; Division of Psychiatry, Faculty of Brain Sciences, University College London, London, UK., Lawrence V; Health Services & Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK., Jones R; Division of Psychiatry, Faculty of Brain Sciences, University College London, London, UK., Livingston G; Division of Psychiatry, Faculty of Brain Sciences, University College London, London, UK., Wilkinson P; Department of Psychiatry, University of Oxford, Oxford, UK., Walters K; Department of Primary Care and Population Health, University College London, London, UK., Novere ML; Department of Primary Care and Population Health, University College London, London, UK., Howard RJ; Division of Psychiatry, Faculty of Brain Sciences, University College London, London, UK.

Publikováno v: Health technology assessment (Winchester, England) [Health Technol Assess] 2021 Sep; Vol. 25 (54), pp. 1-150.